TRDA
Entrada Therapeutics Inc
6.40$
+1.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -129.7% | – | |
| – | +213.5% | +242.6% | +69.7% | +49.9% | +32.8% | +8.6% | |
| – | +10.5% | +677.2% | +291.7% | +32.5% | +36.6% | +9.5% | |
| – | – | +653.6% | +286.4% | – | – | – | |
| – | +62.1% | -1,313.1% | – | – | -187.2% | – | |
| – | +267.9% | +97.6% | -37.0% | +94.5% | -43.7% | -67.0% | |
| – | +267.9% | +97.6% | +3,145.6% | -6.9% | -79.9% | – | |
| – | – | – | -99.9% | +56.0% | +29.6% | -19.5% | |
| – | +131,713.2% | +513.8% | -99.8% | +4,291.9% | +389.4% | -99.1% | |
| – | +31.8% | +1,035.2% | -197.6% | – | +49.7% | -132.2% | |
| – | – | – | – | – | -133.3% | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.